Skip to Content

474 (Pramipexole Dihydrochloride Extended-Release 0.375 mg)

Pill with imprint 474 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 0.375 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.375 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 474

Pramipexole Dihydrochloride Extended-Release

Imprint
474
Strength
0.375 mg
Color
White
Size
11.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0474
Inactive Ingredients
corn starch, calcium phosphate dihydrate dibasic, hydrogenated castor oil, lactose anhydrous, lactose monohydrate, magnesium stearate, mannitol, stearyl alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "474"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.